Siri Kadire

Statistics

Publications

Citations

197

H-Index

Active since

2018

Affiliations

University of California San Diego(Current)

Lenox Hill Hospital

New York University

Indiana University – Purdue University Indianapolis

Cleveland Clinic

Siri Kadire is an author at University of California San Diego specializing in tumor necrosis factor therapy, gastrointestinal pharmacotherapy, and pharmacotherapy.

Publications per year

2018–2021

Publications

Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination

Siri Kadire, Robert M. Wachter, Nicole Lurie · New England Journal of Medicine · 2021 · 78 citations

Veterinary Medicine, Infectious Diseases, Immunization +16

Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis

Dana J. Lukin, David M. Faleck, Ronghui Xu et al. · Clinical Gastroenterology and Hepatology · 2020 · 61 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

OP026 Comparative effectiveness of vedolizumab and TNF-antagonist therapy in ulcerative colitis: a multicentre consortium propensity score-matched analysis

David M. Faleck, Preeti Shashi, Joseph Meserve et al. · Journal of Crohn s and Colitis · 2018 · 14 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16

OP025 Comparative effectiveness of vedolizumab and tumour necrosis factor-antagonist therapy in Crohn’s disease: a multicentre consortium propensity score-matched analysis

Matthew Bohm, Sashidhar Sagi, Monika Fischer et al. · Journal of Crohn s and Colitis · 2018 · 13 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Unusual Presentation of Duodenal Ulcer Presenting with Duodenal Intussusception

Shilpa Lingala, Andrew Moore, Siri Kadire et al. · ACG Case Reports Journal · 2018 · 11 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +13

1–5 of 7